Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville,, TN
SEC filing record 1 source field available
Fiscal year end
31 December
CUMBERLAND PHARMACEUTICALS INC has filed 1,032 SEC EDGAR filings since 02 May 2002

SEC filing history

Showing 776-800 of 959 matching filings.

Per page
25
Current page
32
4

FORM 4 SUBMISSION

Filing date
27 Mar 2013
Reporting date
26 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Mar 2013
Reporting date
26 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Mar 2013
Reporting date
26 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Mar 2013
Reporting date
26 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Mar 2013
Reporting date
26 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Mar 2013
Reporting date
26 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
20 Mar 2013
Reporting date
14 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2013
Reporting date
18 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33637

DEF 14A

Filing date
14 Mar 2013
Reporting date
16 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
04 Mar 2013
Reporting date
01 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
26 Feb 2013
Reporting date
25 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
21 Feb 2013
Reporting date
21 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85205

SC 13G

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

SC 13G/A

Filing date
14 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
01 Feb 2013
Reporting date
01 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85205

SC 13G filing

Filing date
30 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-142535

CT ORDER filing

Filing date
22 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
11 Jan 2013
Reporting date
07 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85205

CUMBERLAND PHARMACEUTICALS INC. SC 13G/A

Filing date
08 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

LIVE FILING

Filing date
30 Nov 2012
Reporting date
29 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2012
Reporting date
15 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

LIVE FILING

Filing date
16 Nov 2012
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-184091

EFFECT filing

Filing date
15 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .